A REASSESSMENT OF THE EXPECTED DEVELOPMENT CONSEQUENCES OF TSETSE CONTROL EFFORTS IN AFRICAMATZKE G.1983; SOCIAL SCIENCE & MEDICINE (1982); ISSN 0277-9536; GBR; DA. 1983; VOL. 17; NO 9; PP. 531-537; BIBL. 26 REF.Article

SETTLEMENT AND SLEEPING SICKNESS CONTROL: A DUAL THRESHOLD MODEL OF COLONIAL AND TRADITIONAL METHODS IN EAST AFRICAMATZKE G.1979; SOC. SCI. MED., D; GBR; DA. 1979; VOL. 13; NO 4; PP. 209-214; BIBL. 10 REF.Article

Die Bärwurzwiesen (Meo-Festucetum Bartsch 1940) der West-Eifel = Les «prairies à méon» (Meo-Festuceum Bartsch 1940) de l'ouest d'Eifel = The «spignet-meadows» (Meo-Festuceum Bartsch 1940) of West EifelMATZKE, G.Tuexenia. 1989, Num 9, pp 303-315, issn 0722-494XArticle

Pharmacotherapeutic consequences of recent advances in hemodialysis therapyMATZKE, G. R.The Annals of pharmacotherapy. 1994, Vol 28, Num 4, pp 512-514, issn 1060-0280Article

ERFAHRUNGEN MIT DER SUPRAPUBISCHEN URINABLEITUNG NACH GYNAEKOLOGISCHEN OPERATIONEN. = LES RESULTATS OBTENUS AVEC LA DERIVATION URINAIRE SUPRA-PUBIENNE APRES LES INTERVENTIONS GYNECOLOGIQUESRABER G; MATZKE G; CANZLER E et al.1975; ZBL. GYNAEKOL.; DTSCH.; DA. 1975; VOL. 97; NO 20; PP. 1263-1267; ABS. ANGL.; BIBL. 16 REF.Article

DIE SUPRAPUBISCHE BLASENPUNKTION IM RAHMEN DER BAKTERIOLOGISCHEN HARNDIAGNOSTIK BEI GYNAEKOLOGISCH-GEBURTS-HILFLICHEN PATIENTINNEN. = LA PONCTION VESICALE SUPRA-PUBIENNE DANS LE CADRE DU DIAGNOSTIC URINAIRE BACTERIOLOGIQUE CHEZ LES MALADES GYNECOLOGIQUES-OBSTETRICALESCANZLER E; JUERGENS H; HERRMANN M et al.1977; ZBL. GYNAEKOL.; DTSCH.; DA. 1977; VOL. 99; NO 13; PP. 784-795; ABS. ANGL.; BIBL. 41 REF.Article

Drug administration in patients with renal insufficiency : Minimising renal and extrarenal toxicityMATZKE, G. R; FRYE, R. F.Drug safety. 1997, Vol 16, Num 3, pp 205-231, issn 0114-5916Article

Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agentsMATZKE, G. R.American journal of kidney diseases. 1996, Vol 28, Num 1, pp S63-S70, issn 0272-6386, SUP1Conference Paper

Clinical pharmacokinetics 1990MATZKE, G. R; ST PETER, W. L.Clinical pharmacokinetics. 1990, Vol 18, Num 1, pp 1-19, issn 0312-5963Article

Contribution of 5-(4-hydroxyphenyl)-5-phenylhydantoin to the discrepancy between phenytoin analyses by EMIT and high-pressure liquid chromatographySAWCHUK, R. J; MATZKE, G. R.Therapeutic drug monitoring. 1984, Vol 6, Num 1, pp 97-103, issn 0163-4356Article

Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysisPETERSON, P. K; MATZKE, G; KEANE, W. F et al.Reviews of infectious diseases. 1987, Vol 9, Num 3, pp 604-612, issn 0162-0886Conference Paper

Stability of gentamicin and tobramycin in concentrate solutions for automated peritoneal dialysisNANCE, K. S; MATZKE, G. R.American journal of nephrology. 1984, Vol 4, Num 4, pp 240-243, issn 0250-8095Article

Secondary aliphatic polyether amines for polyurea RIM systemsMALETZKO, C; BECKER, J; SCHMIDT, H. U et al.Journal of elastomers and plastics. 1992, Vol 24, Num 4, pp 350-362, issn 0095-2443Article

Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysisMILLIKIN, S. P; MATZKE, G. R; KEANE, W. F et al.Peritoneal dialysis international. 1991, Vol 11, Num 3, pp 252-260, issn 0896-8608, 9 p.Article

Clinical pharmacokinetics of vancomycinMATZKE, G. R; ZHANEL, G. G; GUAY, D. R. P et al.Clinical pharmacokinetics. 1986, Vol 11, Num 4, pp 257-282, issn 0312-5963Article

Hemodialysis elimination rates and clearance of gentamicin and tobramycinMATZKE, G. R; HALSTENSON, C. E; KEANE, W. F et al.Antimicrobial agents and chemotherapy. 1984, Vol 25, Num 1, pp 128-130, issn 0066-4804Article

Protein binding of phenytoin, p-hydroxy phenytoin, and p-hydroxy phenytoin glucuronideMATZKE, G. R; BRUNDAGE, R. C; SAWCHUK, R. J et al.Journal of clinical pharmacology. 1986, Vol 26, Num 8, pp 677-679, issn 0091-2700Article

Validity of creatinine clearance estimates in the assessment of renal functionLUKE, D. R; HALSTENSON, C. E; OPSAHL, J. A et al.Clinical pharmacology and therapeutics. 1990, Vol 48, Num 5, pp 503-508, issn 0009-9236, 6 p.Article

Disposition of ceftazidime in surgical patients with intra-abdominal infectionHEIM-DUTHOY, K. L; BUBRICK, M. P; COCCHETTO, D. M et al.Antimicrobial agents and chemotherapy. 1988, Vol 32, Num 12, pp 1845-1847, issn 0066-4804Article

Aminoglycoside redistribution phenomenon after hemodialysis: netilmicin and tobramycinHALSTENSON, C. E; BERKSETH, R. O; MANN, H. J et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1987, Vol 25, Num 1, pp 50-55, issn 0174-4879Article

Disposition of vancomycin during hemofiltrationMATZKE, G. R; O'CONNELL, M. B; COLLINS, A. J et al.Clinical pharmacology and therapeutics. 1986, Vol 40, Num 4, pp 425-430, issn 0009-9236Article

Lack of pharmacodynamic interaction between pentoxifylline and warfarin in the ratLUKE, D. R; O'DONNELL, M. P; KEANE, W. F et al.Research communications in chemical pathology and pharmacology. 1986, Vol 54, Num 1, pp 65-72, issn 0034-5164Article

The effect of hemodialysis on piperacillin pharmacokineticsHEIM-DUTHOY, K. L; HALSTENSON, C. E; ABRAHAM, P. A et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1986, Vol 24, Num 12, pp 680-684, issn 0174-4879Article

Analytical accuracy of determinations of aminoglycoside concentrations by enzyme multiplied immunoassay, fluorescence polarization immunoassay, and radioimmunoassay in the presence of heparinÓCONNELL, M. E; HEIM, K. L; HALSTENSON, C. E et al.Journal of clinical microbiology (Print). 1984, Vol 20, Num 6, pp 1080-1082, issn 0095-1137Article

Validation of the five-drug Pittsburgh cocktail approach for assessment of selective regulation of drug-metabolizing enzymesFRYE, R. F; MATZKE, G. R; ADEDOYIN, A et al.Clinical pharmacology and therapeutics. 1997, Vol 62, Num 4, pp 365-376, issn 0009-9236Article